Form 8-K - Current report:
SEC Accession No. 0001193125-25-071389
Filing Date
2025-04-02
Accepted
2025-04-02 16:31:12
Documents
13
Period of Report
2025-03-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d906738d8k.htm   iXBRL 8-K 25883
  Complete submission text file 0001193125-25-071389.txt   147949

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vrca-20250331.xsd EX-101.SCH 2849
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20250331_lab.xml EX-101.LAB 17993
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20250331_pre.xml EX-101.PRE 11260
15 EXTRACTED XBRL INSTANCE DOCUMENT d906738d8k_htm.xml XML 3613
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 25805237
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)